| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Medicenna Therapeutics Corp (TO: MDNA)
MDNA Technical Analysis
4
| As on 20th Dec 2024 MDNA STOCK Price closed @ 1.71 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.95 & Strong Buy for SHORT-TERM with Stoploss of 0.52 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MDNASTOCK Price
| Open | 1.68 | Change | Price | % |
| High | 1.72 | 1 Day | 0.03 | 1.79 |
| Low | 1.67 | 1 Week | -0.08 | -4.47 |
| Close | 1.71 | 1 Month | -0.76 | -30.77 |
| Volume | 30174 | 1 Year | 1.05 | 159.09 |
| 52 Week High 2.85 | 52 Week Low 0.22 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| CNQ | 42.50 | 0.05% |
| ENB | 59.43 | 1.49% |
| BB | 5.27 | 23.13% |
| ABX | 22.22 | 1.41% |
| TWM | 0.12 | 0.00% |
| FCU | 0.74 | -2.63% |
| PPL | 52.36 | 0.89% |
| CVE | 20.71 | 0.24% |
| TD | 76.09 | 0.44% |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| MDNA Daily Charts |
MDNA Intraday Charts |
Whats New @ Bazaartrend |
MDNA Free Analysis |
|
|
MDNA Important Levels Intraday
| RESISTANCE | 1.81 |
| RESISTANCE | 1.78 |
| RESISTANCE | 1.76 |
| RESISTANCE | 1.74 |
| SUPPORT | 1.68 |
| SUPPORT | 1.66 |
| SUPPORT | 1.64 |
| SUPPORT | 1.61 |
MDNA Forecast December 2024
| 4th UP Forecast | 2.11 |
| 3rd UP Forecast | 1.98 |
| 2nd UP Forecast | 1.9 |
| 1st UP Forecast | 1.82 |
| 1st DOWN Forecast | 1.6 |
| 2nd DOWN Forecast | 1.52 |
| 3rd DOWN Forecast | 1.44 |
| 4th DOWN Forecast | 1.31 |
MDNA Weekly Forecast
| 4th UP Forecast | 2.00 |
| 3rd UP Forecast | 1.91 |
| 2nd UP Forecast | 1.85 |
| 1st UP Forecast | 1.79 |
| 1st DOWN Forecast | 1.63 |
| 2nd DOWN Forecast | 1.57 |
| 3rd DOWN Forecast | 1.51 |
| 4th DOWN Forecast | 1.42 |
MDNA Forecast2024
| 4th UP Forecast | 7.03 |
| 3rd UP Forecast | 5.32 |
| 2nd UP Forecast | 4.27 |
| 1st UP Forecast | 3.21 |
| 1st DOWN Forecast | 0.21 |
| 2nd DOWN Forecast | -0.85 |
| 3rd DOWN Forecast | -1.9 |
| 4th DOWN Forecast | -3.61 |
Medicenna Therapeutics Corp ( TO Canada Symbol : MDNA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MDNA Business Profile
Medicenna Therapeutics Corp., a clinical stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase 2b clinical trial for the treatment of recurrent glioblastoma (rGBM), as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA55, which has completed Phase 2b clinical trial to treat rGBM; MDNA109, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease (GvHD); MDNA413, a dual IL-4/IL-13 antagonist to treat solid tumors; and MDNA132, an IL-13 Superkine to chimeric antigen receptor T (CAR-T) platform. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, or naked IL-2, IL-4, and IL-13 Superkines. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada. Address: 2 Bloor Street West, Toronto, ON, Canada, M4W 3E2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service